Tag: intracranial aneurysm

First patients enrolled in CERUS study to treat intracranial aneurysms using...

Cerus Endovascular has announced enrolment of the first patients in the CERUS study (Contour Neurovascular System European Pre-Market Unruptured Aneurysm Study). The CERUS study...

Acandis receives European CE mark approval for its ACCERO stent

Acandis has announced that it has received European CE mark approval for its ACCERO stent, which is now available for sale in Europe. The...

First intracranial aneurysm patients treated with BRAVO Flow Diverter

Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has announced that the first patients have been treated with the BRAVO Flow Diverter,...

FDA gives HDE approval for Neuroform Atlas to treat wide neck...

The US Food and Drug Administration has approved the Neuroform Atlas Stent System (Stryker) for marketing under a humanitarian device exemption (HDE). The device...

Cerus Endovascular provides corporate update, announces first-in-man use of intra-saccular stent

Cerus Endovascular has provided an update on its lead development programmes, including the Contour Neurovascular System as well as the NEQSTENT Intra-Saccular Stent. “The past...

Coiling of <5mm aneurysms safe and efficacious in Target registry sub-analysis

Based on a sub-analysis of the data from the prospective Target aneurysm multicentre registry, the coiling of aneurysms <5mm in size with Target coils...

Contour Neurovascular System receives CE mark approval

The Contour Neurovascular System (Cerus Endovascular) has received CE mark approval for the treatment of intracranial aneurysms. Contour is a unique, fine mesh braid...

First patients treated in study of Contour system

The first patients have been enrolled and treated in a prospective, single-arm, multicentre study evaluating the Contour Neurovascular System (Cerus Endovascular). Used for the...

Better neck coverage with “bulged centre” of Barrel device in wide-necked...

A single-centre study reports that stent-assisted coiling with the Barrel stent (Medtronic) is a feasible, safe, and efficient method for embolisation of intracranial wide-necked...

Hydrogel coils beat bare platinum in comparison study

The GREAT randomised controlled trial has confirmed that better outcomes can be achieved with hydrogel coils compared to bare platinum coils for the treatment...

Utility of patient-specific neurovascular models in neurointerventional training

By Andreas MJ Frölich Endovascular aneurysm therapy today is characterised by a rapidly growing and evolving collection of available treatment devices. The challenge in achieving...

Acclino stents feasible in complex bifurcation aneurysms at mid-term follow-up

A new study has found stent-assisted endovascular techniques with Acclino stents (Acandis) are a feasible treatment for complex intracranial aneurysms. Reporting in the Journal...

Medina embolisation device represents “a major step forward” in aneurysm treatment

According to a report of a single centre’s experience using the Medina embolisation device (Medtronic) for the treatment of unruptured aneurysms, the device “represents...

High rate of aneurysm occlusion with p64 at mid- and long-term...

Investigators using the p64 Flow Modulation Device (Phenox) for the treatment of unruptured intracranial aneurysms at six centres have revealed that mid- and long-term...

ANSWER study for wide-neck aneurysms meets primary endpoints

In the ANSWER (Adjunctive neurovascular support of wide-neck aneurysm embolization and reconstruction) study of the PulseRider device (Pulsar Vascular), enrolment, 30-day and 180-day follow-up...

Medina Embolization Device and Pipeline Shield: LINNC Wrap Up Interviews

Find the latest updates from Prof Monika Killer and Dr Saleh Lamin following this year’s LINNC Congress in Paris. We consider our latest technologies,...

New aneurysm device acts as both flow disruptor and diverter

The Contour Neurovascular System (Cerus Endovascular) will offer a new option for treating intracranial aneurysms. According to Kyriakos Lobotesis, Principle Clinical Advisor at Cerus,...

Terumo acquires Sequent Medical

Terumo Corporation has announced that it has entered into an agreement to purchase Sequent Medical, known for its WEB aneurysm embolisation device. The purchase price...

Medina Embolization Device

Medina™ is designed as an intra-saccular flow diverter, diverting flow away from the aneurysm sac and through the parent artery by forming a mesh scaffold...

Penumbra Coil 400 safe and effective in small aneurysms

The results of a multicentre study have shown that catherisation with the larger profile coil delivery microcatheter and aneurysm occlusion with large volume coils...

Sequent Medical initiates study of WEB aneurysm embolisation system for ruptured...

Sequent Medical has begun enrolling patients in a study which will evaluate the safety and effectiveness of the WEB (woven endobridge) aneurysm embolisation system...

First coil key during PulseRider procedures in wide-neck aneurysms

At the 2015 annual meeting of the European Society of Minimally Invasive Neurological Therapy (ESMINT; 10–12 September, Nice, France) Gyula Gal (Department of Radiology,...

Almost no learning curve with Barrel reconstruction device

The Barrel Vascular Reconstruction device (Medtronic) is one of the newest offerings for the treatment of intracranial bifurcation aneurysms. Since receiving the CE mark...

Enrolment complete for PulseRider US clinical trial

Pulsar Vascular has announced that they have reached the target enrolment in their clinical trial for PulseRider device for the treatment of intracranial aneurysms....

New device is “equivalent to, or better than” known flow diverters...

In the first study to be published reporting on endovascular aneurysm treatment with the p64 flow modulation device (Phenox), Francesco Briganti and colleagues have found that the device provides a safe procedure with no technical complications.

Phenox launches pToWin study to assess efficacy of pCONus bifurcation aneurysm...

Phenox GmbH has announced the start of the pToWin study after enrolling the first patient on 2 September, 2015. The prospective, multicentre, single-arm study...

Medtronic acquires Medina Medical

Medtronic plc has announced that it has acquired Medina Medical, a Menlo Park, California, USA-based and privately-held medical device company focused on commercialising state-of-the-art...

Radiation reduced with flow diversion for treatment of internal carotid artery...

According to new research, treatment of large and giant proximal internal carotid artery aneurysms using the Pipeline embolisation device (Covidien/Medtronic) requires less radiation, less...

Sequent Medical announces long-term clinical data and commercial release of its...

Sequent Medica has announced the presentation of prospective long-term clinical data for the WEB aneurysm embolisation system at the Societe Francaise de Neuroradiologie (SFNR)...

Next generation Medina coil system shows improvements in early human experience

In early use of the Medina coil system, researchers have found the device to be a next generation coil that combines the familiar procedural safety and technique associated with conventional coils, with improved circumferential aneurysm filling, which, they say, it is thought will lead to improved long-term outcomes.

FDA approves Pipeline Flex embolisation device

Designed to divert blood flow away from an aneurysm, the Pipeline Flex embolisation device (Medtronic) features a braided cylindrical mesh tube that is implanted across the base or neck of the aneurysm.

PulseRider safe and effective in early USA experience

Initial experience with PulseRider (Pulsar Vascular) has shown the device to be safe and effective as an adjunct in the treatment of bifurcation aneurysms arising at the basilar apex or carotid terminus.

Medina Medical announces CE mark for its embolisation coil

Medina Medical has announced that it has received CE mark authorisation for its Embolization Framing Coil for commercial distribution in the European Union.

Codman Neuro gains exclusive rights to market and promote PulseRider in...

PulseRider is a minimally invasive device intended for use with embolic coils in the treatment of unruptured wide-neck intracranial aneurysms originating on or near a bifurcation.

FDA IDE approval for PulseRider

The IDE allows Pulsar Vascular to begin a multicentre clinical trial in support of a humanitarian device exemption (HDE) to evaluate the PulseRider for US approval for wide neck aneurysms at or near a bifurcation of the basilar tip or carotid terminus.

Pulsar Vascular gets CE mark for Pulserider

Pulsar Vascular announced that it has received European CE mark approval for Pulserider. This unique implant is used to bridge the neck of cerebral aneurysms previously not amenable to endovascular therapy. This new device is implanted via standard, minimally invasive, endovascular techniques thus providing an alternative treatment option to open surgery.

Phenox receives CE mark approval for pCONus Bifurcation Aneurysm Implant

The pCONus implant for treatment of complex, wide neck intracranial bifurcation aneurysms has been granted the CE mark for commericalisation in Europe.

Phenox receives CE mark approval for p64 Flow Modulation Device

The p64 Flow Modulation Device is an intraluminal flow diverter for treatment of complex intracranial aneurysms and dissections.